Zydus receives final approval from the USFDA for Clindamycin Phosphate and Benzoyl Peroxide Gel

Deepthi | Myequity news | Date : 29-12-2018 17:25:00 IST

Zydus Cadila has received the final approval from the USFDA to market Clindamycin Phosphate and Benzoyl Peroxide Gel, (US RLD —DUAC® Gel), 1.2%/5%. It will be manufactured at the group’s Topical manufacturing facility at Ahmedabad.

This combination medication is used to treat a certain type of acne (inflammatory acne vulgaris). It helps to decrease the number of acne pimples. Clindamycin is an antibiotic that stops the growth of acne-causing bacteria. Benzoyl peroxide can also stop the growth of bacteria as well as reduce oil production in the skin.

About Zydus Cadila:

Zydus Cadila is an innovative, global pharmaceutical company that discovers, develops, manufactures and markets a broad range of healthcare therapies.


More from Myequity